HBCMD01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HBCMD01, covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.